Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 16.35M P/E - EPS this Y -8.40% Ern Qtrly Grth -
Income -9.8M Forward P/E -1.14 EPS next Y 22.20% 50D Avg Chg -22.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -26.00%
Dividend N/A Price/Book 4.90 EPS next 5Y - 52W High Chg -59.00%
Recommedations 2.00 Quick Ratio 0.45 Shares Outstanding 19.47M 52W Low Chg 12.00%
Insider Own 25.43% ROA -150.79% Shares Float 12M Beta -
Inst Own 8.58% ROE - Shares Shorted/Prior 385.62K/140.02K Price 1.20
Gross Margin - Profit Margin - Avg. Volume 66,137 Target Price -
Oper. Margin - Earnings Date Oct 1 Volume 30,519 Change -4.76%
About NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel.

NeuroSense Therapeutics Ltd. News
11/21/24 NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND
10/28/24 NeuroSense Secures Key FDA Meeting to Advance its Phase 3 ALS Trial and NDA Submission
10/28/24 EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission
10/24/24 New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients
10/15/24 NeuroSense Advances Plans for Early Commercialization of Groundbreaking ALS Treatment in Canada, Provides Further Updates
10/09/24 NeuroSense Therapeutics Plans to File for Early Commercialization of ALS Treatment in Canada
10/07/24 NeuroSense Therapeutics Announces Acceptance of Two PrimeC Abstracts at the 2024 NEALS Annual Meeting
09/24/24 NeuroSense Therapeutics Granted Key U.S. Patent for Novel PrimeC Formulation, its Lead Asset for ALS and Alzheimer's
09/24/24 NeuroSense Regains Compliance with NASDAQ Minimum Bid Price Rule
08/30/24 NeuroSense Therapeutics Announces Receipt of Nasdaq Minimum Bid Price Notification
08/28/24 EXCLUSIVE: NeuroSense Therapeutics In Advanced Talks With Several Multi-Billion-Dollar Pharma Companies To Partner Its Lead Drug
08/07/24 NeuroSense Therapeutics Announces Private Placement with Senior Management Participation at Premium to Market Price
08/01/24 NeuroSense Therapeutics Announces Positive Biomarker Data from ALS Phase 2b Clinical Trial
07/09/24 NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression
07/01/24 NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug
06/24/24 NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results
06/21/24 NeuroSense Receives Delisting Notice from Nasdaq and Intends to Appeal
05/20/24 NeuroSense Vice President of R&D Shiran Zimri, Ph.D. to Participate in the 3rd Annual ALS Drug Development Summit
05/14/24 NeuroSense Partners with PhaseV to Optimize Upcoming ALS Phase 3 Trial Using Advanced Causal Machine Learning
05/07/24 NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients
NRSN Chatroom

User Image Speculator2 Posted - 2 days ago

$NRSN They are diluting with another 10m shares per their latest filing.

User Image boilerrm04 Posted - 2 days ago

$NRSN 18,055,006 Current Outstanding Ordinary Shares 1,060,128 2018 ESOP $2.31 per share 284,000 Vested 2018 Share Incentive Plan 848,705 Reserved for Issuance 2018 Share Incentive Plan 8,535,000 Warrants at $2.38 224,697 Issued shares to Yorkville for 36 month committement purchase 9,775,303 Advanced shares at $1.18 per share in the future 38,782,839 Current outstanding shares and warrants as of 11/21/24 90,000,000 Authorized Share Count, only 20,709, 481 are issued as of 11/19/24

User Image Speculator2 Posted - 2 days ago

$NRSN Still not meeting Nasdaq compliance nearly a month after the extended deadline, and no filing to report another extension.

User Image Cohensha Posted - 2 days ago

Why $NRSN fall this week?, Anyway, I really confident in this company and will add more shares as I can

User Image PenkeTrading Posted - 2 days ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Neurosense Therapeutics Ltd. Is that bullish or bearish? $NRSN #Neurosense #RsiOversold #NASDAQ

User Image bourne86 Posted - 3 days ago

$NRSN Sec From F-1 https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=318732336&type=HTML&cdn=a305f1767ecb0e7a855ffc1ce8e7cd54&formType=F-1&dateFiled=2024-11-19&cik=1875091&symbol=1875091&companyName=

User Image BioRich Posted - 3 days ago

$TNXP TNXP keeps getting better. Today's bump might just be a foreshadow of what's to come. This news, alone, should place SP above a buck. For easy reference, here's the big news regarding $TNXP and their very promising Phase 3 confirmatory trial: "Poster presentation highlighted results from confirmatory Phase 3 RESILIENT study of TNX-102 SL (sublingual cyclobenzaprine HCl) treatment demonstrating statistically significant improvement in primary endpoint of fibromyalgia nociplastic pain and in all six key secondary endpoints, including sleep quality" Key words: * Confirmatory Phase 3 study * Statistically significant improvement in primary endpoint * And in all six key secondary endpoints * Including sleep quality $BURU $TANH $NRSN or $BCTX next? Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. Let's make some money. Cheers!

User Image funnymoney90210 Posted - 4 days ago

$NRSN

User Image BossBishhh28 Posted - 1 week ago

$NRSN ALL my bios got ripped apart the last few days. 😳

User Image iBoughtTheWrongTicker Posted - 1 week ago

$NRSN nice we just found out not only is Sparrow88 losing his (_(_) but he’s super sensitive about it lol. Awwww, he reported me. Oh well…good tidings friend

User Image defman Posted - 1 week ago

$NRSN in it with y'all, long here, but was also had a long trudge with $CYN and lookit me now! Take a look!

User Image RobbyDGod Posted - 1 week ago

$NRSN warrants are fraud ... how could the spread be .12 to .35 ... that's BS

User Image BioRich Posted - 1 week ago

@History101 @Stefan2711 thanks for the share. I'm high on $SLS and think they can run for awhile once they get sufficient traction. I've liked $NRSN and think they have a solid future. $TNXP is one that I always tie to $NRSN for some reason (I think I bought them the same day, along with $TANH). Their news has been pretty solid, share price, not so much. Out of your list, which are your top 3 short-term (i.e., day/week) and top-3 long-term >3 months (not scientific, just made up a mental timeframe).

User Image boilerrm04 Posted - 1 week ago

$NRSN extending Nasdaq compliance until next month is also a good sign!

User Image Jethro18 Posted - 1 week ago

$NRSN Today would be a good day to tell everyone about what they learned from the FDA meeting on Nov 6th. Every day after today would also be good.

User Image BossBishhh28 Posted - 1 week ago

$NRSN daaaaang

User Image bourne86 Posted - 1 week ago

$NRSN https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=318704861&type=HTML&cdn=ba8be042ec5ca1524d299cc0d74b66cc&formType=6-K&dateFiled=2024-11-12&cik=1875091&symbol=1875091&companyName=

User Image CanadianMoneyMaker Posted - 1 week ago

$NRSN can anyone here provide some insight/opinions into the timelines for approval in Canada. If they can get that and get some sales traction 25 mill market cap becomes 250 million awfully quick. Or is this just smoke and mirrors. Thoughts?

User Image BioRich Posted - 1 week ago

$JL keep that creeping on up. $NEGG $NBY $NRSN and $XFOR looking to continue as money makers. Follow/Subscribe for more suggestions and perspectives. Would love to hear yours as well! Let's make some money. Cheers!

User Image BossBishhh28 Posted - 1 week ago

$NRSN this three month chart is fire y’all

User Image jacksparo Posted - 1 week ago

$NRSN What a nice chart!

User Image Itay_Bio_Invest Posted - 2 weeks ago

$NRSN So quiet here today.

User Image 1111t11 Posted - 2 weeks ago

$NRSN https://m-investing-com.cdn.ampproject.org/c/s/m.investing.com/analysis/4-biotech-stocks-with-ai-machine-learning-prowess-200653918?ampMode=1

User Image Mikeqb20 Posted - 2 weeks ago

$NRSN WATCH THIS VIDEO AND BUY THE CRAP OUT OF THE STOCK you MOFO's https://www.youtube.com/watch?v=b66Dcmo11KE

User Image Mulhollandr Posted - 2 weeks ago

$CLNN seriously. Buy more on dips. Then just keep holding. Multiple treatments in the near future, ALS, MS, Parkinsons! $BCLI $NRSN https://www.reddit.com/r/MultipleSclerosis/s/4b9uaUOlF5

User Image 1111t11 Posted - 2 weeks ago

$NRSN fda????

User Image iBoughtTheWrongTicker Posted - 2 weeks ago

$NRSN I wish Sparrow would post so we could break $1.40…

User Image black_ambition Posted - 2 weeks ago

$NRSN Nice feature video https://www.linkedin.com/posts/nyassin_a-few-months-ago-i-shared-alons-mission-activity-7259912671838294016-i_V-?utm_source=share&utm_medium=member_desktop

User Image iBoughtTheWrongTicker Posted - 2 weeks ago

$NRSN wowza

User Image Cohensha Posted - 2 weeks ago

$NRSN ad at Ben Zinga, making great PR recently. https://www.linkedin.com/posts/benzinga_als-primec-biotech-activity-7259625063987974144-5Mdk?utm_source=share&utm_medium=member_ios